{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T09:22:31Z","timestamp":1786785751625,"version":"build-2736575974"},"reference-count":27,"publisher":"American Medical Association (AMA)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Ophthalmol"],"published-print":{"date-parts":[[2024,12,1]]},"abstract":"<jats:sec id=\"ab-eoi240071-4\"><jats:title>Importance<\/jats:title><jats:p>The association of race and detection of pathogenic variants using wide-panel genetic testing for inherited retinal diseases (IRD), to our knowledge, has not been studied previously.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240071-5\"><jats:title>Objective<\/jats:title><jats:p>To investigate the genetic detection rates of wide-panel testing in Black and non-Hispanic White patients with IRDs.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240071-6\"><jats:title>Design, Setting, Participants<\/jats:title><jats:p>This 2-group comparison used retrospective patient data that were collected at the University of Michigan (UM) and Blueprint Genetics (BG). At UM, inclusion criteria included having a clinical IRD diagnosis, wide-panel genetic testing, and both parents and the patient self-identifying as the same race (Black or non-Hispanic White). Logistic regression analysis was used; the dependent variable was genetic test result (positive or negative\/inconclusive) and the independent variables were race, age, sex, phenotype, and number of genes tested. In the BG database, patients with wide-panel testing and self-reported race were included; detection rate comparison analysis based on race was performed using \u03c7<jats:sup>2<\/jats:sup> test of independence. These data were analyzed from October 30, 2013, through October 26, 2022.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240071-7\"><jats:title>Main Outcome and Measure<\/jats:title><jats:p>Genetic test result was considered positive if pathogenic\/likely pathogenic variants were detected.<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240071-8\"><jats:title>Results<\/jats:title><jats:p>A total of 572 patients were included in UM, 295 were males (51.6%). Mean age was 45 years. There were 54 Black patients (9.4%) and 518 White patients (90.6%). Black race (odds ratio [OR], 0.25; 95% CI, 0.14-0.46; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) and age (OR per 10 years, 0.84; 95% CI, 0.76-0.92; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001) were independently associated with decreased odds of a positive test. In the BG database, 142 of 320 of Black patients (44.4%) had a positive\/likely positive test result, a proportion lower than White patients (1691 of 2931 [57.7%]) (\u03c7<jats:sup>2<\/jats:sup>\u2009=\u200918.65; <jats:italic>df<\/jats:italic>\u2009=\u20091; <jats:italic>P<\/jats:italic>\u2009&amp;amp;lt;\u2009.001).<\/jats:p><\/jats:sec><jats:sec id=\"ab-eoi240071-9\"><jats:title>Conclusions and Relevance<\/jats:title><jats:p>Results from this study highlight a lower genetic detection rate for Black patients than for White patients with IRDs. This supports a concern that the current development of IRD therapeutics is highly dependent on the ability to identify the genetic cause of disease. Patients with no known genetic diagnosis may be disadvantaged in terms of prognostication, inheritance counseling, reproductive decision-making, and eligibility for potential therapeutic options, including clinical trials. As future treatments become available, these findings suggest the need to examine the genetic detection rates across majority and minority subgroups alike.<\/jats:p><\/jats:sec>","DOI":"10.1001\/jamaophthalmol.2024.4696","type":"journal-article","created":{"date-parts":[[2024,11,7]],"date-time":"2024-11-07T16:32:10Z","timestamp":1730997130000},"page":"1150","source":"Crossref","is-referenced-by-count":11,"title":["Racial Disparities in Genetic Detection Rates for Inherited Retinal Diseases"],"prefix":"10.1001","volume":"142","author":[{"given":"Rebhi O.","family":"Abuzaitoun","sequence":"first","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari H.","family":"Branham","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabrielle D.","family":"Lacy","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert B.","family":"Hufnagel","sequence":"additional","affiliation":[{"name":"Medical Genetics and Ophthalmic Genomics Unit, Ophthalmic Genomics Laboratory, National Eye Institute, National Institutes of Health, Bethesda, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenakshi M.","family":"Kumar","sequence":"additional","affiliation":[{"name":"Blueprint Genetics Ltd, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha W.","family":"Koskenvuo","sequence":"additional","affiliation":[{"name":"Blueprint Genetics Ltd, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sari","family":"Tuupanen","sequence":"additional","affiliation":[{"name":"Blueprint Genetics Ltd, Helsinki, Finland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd","family":"Durham","sequence":"additional","affiliation":[{"name":"Foundation Fighting Blindness, Columbia, Maryland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter Y.","family":"Zhao","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Fernanda","family":"Abalem","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"},{"name":"Department of Ophthalmology and Otolaryngology, University of Sao Paulo Medical School, S\u00e3o Paulo, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris A.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Schlegel","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naheed W.","family":"Khan","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abigail T.","family":"Fahim","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R.","family":"Heckenlively","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C.","family":"Musch","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"},{"name":"Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Thiran","family":"Jayasundera","sequence":"additional","affiliation":[{"name":"Kellogg Eye Center, Department of Ophthalmology and Visual Sciences, University of Michigan Medical School, Ann Arbor, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"8","key":"eoi240071r1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0238295","article-title":"Gene panel screening for insight towards breast cancer susceptibility in different ethnicities.","volume":"15","author":"Bishop","year":"2020","journal-title":"PLoS One"},{"issue":"10","key":"eoi240071r3","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.ophtha.2020.04.008","article-title":"Genetic basis of inherited retinal disease in a molecularly characterised cohort of over 3000 families from the United Kingdom.","volume":"127","author":"Pontikos","year":"2020","journal-title":"Ophthalmology"},{"issue":"5","key":"eoi240071r4","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology.","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"5","key":"eoi240071r6","doi-asserted-by":"publisher","first-page":"2710","DOI":"10.1073\/pnas.1913179117","article-title":"Worldwide carrier frequency and genetic prevalence of autosomal recessive inherited retinal diseases.","volume":"117","author":"Hanany","year":"2020","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"14","key":"eoi240071r7","doi-asserted-by":"publisher","first-page":"6374","DOI":"10.1167\/iovs.16-19785","article-title":"Molecular diagnosis of inherited retinal diseases in indigenous African populations by whole-exome sequencing.","volume":"57","author":"Roberts","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"10","key":"eoi240071r8","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.ophtha.2020.04.008","article-title":"Genetic basis of inherited retinal disease in a molecularly characterized cohort of more than 3000 families from the United Kingdom.","volume":"127","author":"Pontikos","year":"2020","journal-title":"Ophthalmology"},{"issue":"9","key":"eoi240071r9","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.ophtha.2017.04.008","article-title":"Clinically focused molecular investigation of 1000 consecutive families with inherited retinal disease.","volume":"124","author":"Stone","year":"2017","journal-title":"Ophthalmology"},{"issue":"1","key":"eoi240071r10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.ajhg.2016.12.003","article-title":"Comprehensive rare variant analysis via whole-genome sequencing to determine the molecular pathology of inherited retinal disease.","volume":"100","author":"Carss","year":"2017","journal-title":"Am J Hum Genet"},{"issue":"6","key":"eoi240071r11","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1038\/s41436-020-0759-8","article-title":"Copy-number variation contributes 9% of pathogenicity in the inherited retinal degenerations.","volume":"22","author":"Zampaglione","year":"2020","journal-title":"Genet Med"},{"issue":"1","key":"eoi240071r12","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3390\/genes11010105","article-title":"Findings from a genotyping study of over 1000 people with inherited retinal disorders in Ireland.","volume":"11","author":"Whelan","year":"2020","journal-title":"Genes (Basel)"},{"issue":"4","key":"eoi240071r13","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1080\/13816810.2020.1778736","article-title":"Next generation sequencing using phenotype-based panels for genetic testing in inherited retinal diseases.","volume":"41","author":"Shah","year":"2020","journal-title":"Ophthalmic Genet"},{"issue":"1","key":"eoi240071r14","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.ajo.2010.08.047","article-title":"Appropriate use and reporting of uncontrolled case series in the medical literature.","volume":"151","author":"Kempen","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"eoi240071r15","doi-asserted-by":"publisher","DOI":"10.1007\/s10633-014-9473-7","article-title":"ISCEV Standard for full-field clinical electroretinography (2015 update).","author":"McCulloch","year":"2015","journal-title":"Documenta ophthalmologica"},{"issue":"2","key":"eoi240071r16","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1038\/s41436-019-0655-2","article-title":"Adapting ACMG\/AMP sequence variant classification guidelines for single-gene copy number variants.","volume":"22","author":"Brandt","year":"2020","journal-title":"Genet Med"},{"issue":"7","key":"eoi240071r17","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a008524","article-title":"Genetic variation and adaptation in Africa: implications for human evolution and disease.","volume":"6","author":"Gomez","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"issue":"3","key":"eoi240071r18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1038\/clpt.2013.209","article-title":"Warfarin pharmacogenetics: an illustration of the importance of studies in minority populations.","volume":"95","author":"Perera","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"eoi240071r19","doi-asserted-by":"publisher","first-page":"548","DOI":"10.3389\/fgene.2019.00548","article-title":"A review of African Americans\u2019 beliefs and attitudes about genomic studies: opportunities for message design.","volume":"10","author":"Scherr","year":"2019","journal-title":"Front Genet"},{"key":"eoi240071r20","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2019.09.010","article-title":"Ethnic disparities among men with prostate cancer undergoing germline testing.","author":"Kwon","year":"2020","journal-title":"Urol Oncol"},{"issue":"2","key":"eoi240071r21","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1136\/jmg.2005.034744","article-title":"Racial differences in the incidence of BRCA1 and BRCA2 mutations in a cohort of early onset breast cancer patients: African American compared to White women.","volume":"43","author":"Haffty","year":"2006","journal-title":"J Med Genet"},{"issue":"10","key":"eoi240071r22","doi-asserted-by":"publisher","first-page":"6839","DOI":"10.1167\/iovs.14-14246","article-title":"Genetic determinants of age-related macular degeneration in diverse populations from the PAGE study.","volume":"55","author":"Restrepo","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"eoi240071r23","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1038\/ejhg.2013.72","article-title":"Panel-based next generation sequencing as a reliable and efficient technique to detect mutations in unselected patients with retinal dystrophies.","volume":"22","author":"Gl\u00f6ckle","year":"2014","journal-title":"Eur J Hum Genet"},{"issue":"1","key":"eoi240071r24","first-page":"1","article-title":"Panel-based NGS reveals novel pathogenic mutations in autosomal recessive retinitis pigmentosa.","volume":"6","author":"Perez-Carro","year":"2016","journal-title":"Sci Rep"},{"issue":"4","key":"eoi240071r25","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1001\/jamaophthalmol.2021.0004","article-title":"Association of no-cost genetic testing program implementation and patient characteristics with access to genetic testing for inherited retinal degenerations.","volume":"139","author":"Zhao","year":"2021","journal-title":"JAMA Ophthalmol"},{"issue":"7","key":"eoi240071r27","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1167\/tvst.9.7.2","article-title":"Advancing clinical trials for inherited retinal diseases: recommendations from the Second Monaciano Symposium.","volume":"9","author":"Thompson","year":"2020","journal-title":"Transl Vis Sci Technol"},{"key":"eoi240071r2","first-page":"828","volume-title":"Genetic Testing for Inherited Eye Conditions in Over 6,000 Individuals Through the eyeGENE Network","author":"Goetz","year":"2020"},{"key":"eoi240071r5","unstructured":"gnomAD. Genome aggregation databse. Accessed October 3, 2024. https:\/\/gnomad.broadinstitute.org\/"},{"key":"eoi240071r26","unstructured":"US Census Bureau. Census illuminates racial and ethnic composition of the country. Accessed October 3, 2024. https:\/\/www.census.gov\/library\/stories\/2021\/08\/improved-race-ethnicity-measures-reveal-united-states-population-much-more-multiracial.html"}],"container-title":["JAMA Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/articlepdf\/2825835\/jamaophthalmology_abuzaitoun_2024_oi_240071_1733957538.43903.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T16:02:19Z","timestamp":1734624139000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamaophthalmology\/fullarticle\/2825835"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,1]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamaophthalmol.2024.4696","relation":{},"ISSN":["2168-6165"],"issn-type":[{"value":"2168-6165","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12,1]]}}}